Geriatric Migraine, Geroscience, and Sustainable Development Goals: Bridging Clinical Complexity and Public Health Priorities
Migraine in older adults is a significant but often overlooked contributor to disability and reduced quality of life. Improved recognition of its unique clinical features and age-specific vulnerabilities is essential to optimize patient-centered care. Future research should prioritize the inclusion of older populations and the development of tailored, safe, and effective management strategies.
Authors
- Michalis Kodounis (ORCID: https://orcid.org/0000-0003-4549-7607)
- Paolo Martelletti (ORCID: https://orcid.org/0000-0002-6556-4128)
- Bianca Raffaelli (ORCID: https://orcid.org/0000-0001-9758-1494)
- Claudio Tana (ORCID: https://orcid.org/0000-0002-9162-7866)
- Simona Sacco (ORCID: https://orcid.org/0000-0003-0651-1939)
- Marta Waliszewska‐Prosół (ORCID: https://orcid.org/0000-0002-9074-2803)
- Raffaele Ornello (ORCID: https://orcid.org/0000-0001-9501-4031)
- Dilara Onan (ORCID: https://orcid.org/0000-0001-9505-6135)
- William Wells-Gatnik
- Roberta Messina
Institutions
- Texas Tech University (US)
- Vita-Salute San Raffaele University (IT)
- The University of Texas at El Paso (US)
- University of L'Aquila (IT)
- Yozgat Bozok Üniversitesi (TR)
- Wroclaw Medical University (PL)
- Unitelma Sapienza University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Azienda Sanitaria Locale CN2 (IT)
- Eginition Hospital (GR)
- Huazhong University of Science and Technology (CN)
- Charité - Universitätsmedizin Berlin (DE)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/jcm15083088
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- Teva Pharmaceutical Industries
- Ministero della Salute
- H. Lundbeck A/S